Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06727370
Cognitive Screening in Lung Cancer Patients
Sponsor: European Institute of Oncology
View on ClinicalTrials.gov
Summary
This study aims to investigate the occurrence of cancer and adjuvant therapy-related cognitive impairment in patients with both NSCLC and SCLC. The primary endpoint measure will be the presence of cognitive impairment during the first year after enrollment through the administration of a comprehensive neuropsychological assessment.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-01-10
Completion Date
2025-12-31
Last Updated
2024-12-10
Healthy Volunteers
No
Locations (1)
Istituto Europeo di Oncologia
Milan, Italy